Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 58, 1998 - Issue 5
Submit an article Journal homepage
14
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis

M Higuchi First Department of Internal Medicine, Faculty of Medicine,
,
T Horiuchi First Department of Internal Medicine, Faculty of Medicine,
,
T Kojima First Department of Internal Medicine, Faculty of Medicine,
,
H Nishizaka First Department of Internal Medicine, Faculty of Medicine,
,
H Ishibashi First Department of Internal Medicine, Faculty of Medicine,
,
K Hayashi Institute of Genetic Information, Kyushu University, Fukuoka, Japan; and
,
Y Niho First Department of Internal Medicine, Faculty of Medicine,
&
K Nagasawa Department of Internal Medicine, Saga Medical School, Saga, Japan
 show all
Pages 429-432 | Published online: 08 Jul 2009

REFERENCES

  • James SP, Hoofnagle JH, Strober W, Jones EA, Maryland B. Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983; 99: 500 —12.
  • Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570–80.
  • Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, etal. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 1992; 11: 43i3-2i.
  • Splawski JB, Fu SM, Lipsky PE. Immunoregulatory role of CD40 in human B cell differentiation. J Immunol 1993; 50: i276–85.
  • Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovitch A, Nonoyama S, etal. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper IgM syndrome. Cell 1993; 72: 291 —300.
  • Xu J, Foy TM, Laman JD, Elliot EA, Dunn JJ, Waldschmidt TJ, etal. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423–3i.
  • Lin Q, Rohrer J, Allen RC, Larché M, Greene JM, Shigeoka AO, et al. A single strand conformation polymorphism study of CD40 ligand: efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest 1996; 97: 196 — 201.
  • Sasaki H, Inoue K, Higuchi K, Yasuyama T, Koyata H, Kuroki T, etal. Primary biliary cirrhosis in Japan: national survey by the subcommittee on autoimmune hepatitis. Gastroenterol Jpn 1985; 20: 476— 85.
  • Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplifica-tion and sequence determination of a single compo-nent among a mixture of sequence variants. Anal Biochem 1991; 192: 82 — 4.
  • Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97: 2063 —73.
  • Mohan C, Shi Y, Laman JD, Datta SK. Interaction between CD40 and its ligand gp39 in the develop-ment of murine lupus nephritis. J Immunol 1995; 154: 1470 — 80.
  • Blotta MH, Marshall JD, DeKruyff RH, Umetsu DT. Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol 1996; 156: 3133–40.
  • James SP, Elson CO, Jones EA, Strober W. Abnor-mal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology 1980; 79: 242 — 54.
  • Menéndez-Caro JL, Alvarez-Mon M, Girón JA, Manzano L, Garrido A, Abreu L, et al. Increased IgM B cell differentiation lymphokine production by T lymphocytes from patients with primary bili-ary cirrhosis. J Hepatol 1994; 20: 446 — 53.
  • Miller KB, Sepersky RA, Brown KM, Goldberg MJ, Kaplan MM. Genetic abnormalities of immu-noregulation in primary biliary cirrhosis. Am J Med 1983; 75: 75 — 80.
  • Gregory WL, Bassendine MF. Genetic factors in pri-mary biliary cirrhosis. J Hepatol 1994; 20: 689 — 92.
  • Shimoda S, Nakamura N, Ishibashi H, Hayashida K, Niho Y. HLA DRB4 0101-restricted immuno-doninant T cell autoepitope of pyruvate dehydro-genase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoim-mune diseases. J Exp Med 1995; 181: 1835 — 45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.